CalciMedica Inc CALC

Healthcare

CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora, a potent and selective intravenous (IV) formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The Company is conducting a Phase 2b trial (called CARPO - NCT04681066) for acute pancreatitis (AP) with systemic inflammatory response syndrome (SIRS), as well as supporting the ongoing Phase 1/2 asparaginase induced pancreatic toxicity (AIPT) study (called CRSPA - NCT04195347).

NDAQ:CALC - Post by User

CalciMedica Inc

<< Previous

Bullboard Posts

Next >>

Post by alphaflighton May 19, 2021 12:08pm

844 Views

Post# 33230283

Graycliff Exploration Drills 67 g/t Au Over 3M Near Surface

Graycliff Exploration Drills 67 g/t Gold

Over 3.0 Metres Near Surface

TORONTO, ON - May 19, 2021 - Graycliff Exploration Limited (the “Company” or “Graycliff”) (CSE: GRAY) (OTCQB: GRYCF) (FSE: GE0) is pleased to announce limited assay results of the first drill hole of its over 2,000 metre (“m”) phase two core drilling program (see Press Release dated April 22, 2021) on the Company’s Shakespeare Gold Project located on the prolific Canadian Shield near Sudbury, Ontario.

Drill Hole J-8-21 intersected a mineralized interval of 66.98 g/t gold (“Au”) over 3.0 m, as detailed below:

“While the Company is not in the practice of releasing partial results from its drill holes, the results received were significant enough to warrant their immediate release. We are optimistic that the results from the additional samples from hole J-8-21 that are currently at the lab will be available in the near future. Obviously, more than 2 ounces per ton over 3 metres is an exceptional start for our phase two drilling program,” stated President and CEO, James Macintosh.

This high-grade gold intersection in drill hole J-8-21 is located approximately 30 m down-dip of the mineralization reported from drill hole J-7-20 that highlighted an interval grading 8.59 g/t Au over 5.5m (see Cross Section “A-A” in Press Release dated March 24, 2021). Sample materials from several other drill holes have been delivered to the assay lab and those assay results are expected to be available in somewhat regular intervals over the coming weeks.

About Graycliff Exploration Limited.

Graycliff Exploration is a mineral exploration company focused on its 847 hectares of prospective ground, located roughly 80 kilometres west of Sudbury on the prolific Canadian Shield. The Company's Shakespeare Project consists of 39 claims on a property associated with the historic Shakespeare Gold Mine, which operated from 1903 to 1907.